Efficacy of sequential therapy in eradication of Helicobacter Pylori
Phase 2
- Conditions
- Condition 1: Dyspepsia. Condition 2: Helicobacter pylori.DyspepsiaHelicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
- Registration Number
- IRCT2015082323736N1
- Lead Sponsor
- Vice chancellor for research, Lorestan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Patients with Dyspepsia for whom endoscopy was performed and those ones that have the positive Helicobacter Pylori infection based on pathology result and those who have not been treated for Helicobacter Pylori eradication before.
Exclusion criteria: Patients that need more treatments based on endoscopy results, patients that have severe underling diseases (heart disease, kidney disease, liver disease, etc), pregnant and lactating women, patients who have allergies to drugs we want to use.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication of Helicobacter Pylori. Timepoint: 6 weeks after the completion of treatment course. Method of measurement: (UBT) Urea Breath Test.
- Secondary Outcome Measures
Name Time Method Side effects of drugs. Timepoint: 2 Weeks After Beginning of Treatment. Method of measurement: Questionnaire.